Diagnostic and therapeutic recommendations for the treatment of hyperphenylalaninemia in patients 0–4 years of age

BACKGROUND: Treatment of phenylketonuria (PKU) with sapropterin dihydrochloride in responsive patients from an early age can have many advantages for the patient over dietary restriction alone. Accordingly, approval of sapropterin in the European Union was extended in 2015 to include patients aged 0...

Descripción completa

Detalles Bibliográficos
Autores principales: Muntau, Ania C., du Moulin, Marcel, Feillet, Francois
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Position Statement
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6162894/
https://www.ncbi.nlm.nih.gov/pubmed/30268140
http://dx.doi.org/10.1186/s13023-018-0911-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6162894/
https://www.ncbi.nlm.nih.gov/pubmed/30268140
http://dx.doi.org/10.1186/s13023-018-0911-6

Ejemplares similares